Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aybala Saricicek

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
CNS & Neurological Disorders Drug Targets|April 14, 2007
GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant actionGerard Sanacora, Aybala Saricicek
Psychiatry Research|October 2, 2013
Abnormal white matter integrity and decision-making deficits in alcohol dependenceNabi Zorlu, Fazil Gelal, Ali Kuserli, et al.
Psychiatry Research|August 9, 2014
Abnormal white matter integrity in long-term abstinent alcohol dependent patientsNabi Zorlu, Tugba Karavul Ucman, Fazil Gelal, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trialAybala Saricicek, Kathleen Maloney, Anjana Muralidharan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 17, 2009
Enhanced visual motion perception in major depressive disorderJulie D Golomb, Jenika R B McDavitt, Barbara M Ruf, et al.
Neuroimage. Clinical|February 10, 2019
Cortical thickness and surface area as an endophenotype in bipolar disorder type I patients and their first-degree relativesNefize Yalin, Aybala Saricicek, Ceren Hidiroglu, et al.
Psychiatry Research|May 19, 2012
Prefrontal cortical response to emotional faces in individuals with major depressive disorder in remissionRebecca Kerestes, Zubin Bhagwagar, Pradeep J Nathan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2014
Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943Aybala Saricicek, Jason Chen, Beata Planeta, et al.
The American Journal of Psychiatry|July 10, 2012
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorderAybala Saricicek, Irina Esterlis, Kathleen H Maloney, et al.
Molecular Psychiatry|May 21, 2026
White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysisMarjolein E A Barendse, Simon R Poortman, Christopher R K Ching, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
CNS & Neurological Disorders Drug Targets|April 14, 2007
GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant actionGerard Sanacora, Aybala Saricicek
Psychiatry Research|October 2, 2013
Abnormal white matter integrity and decision-making deficits in alcohol dependenceNabi Zorlu, Fazil Gelal, Ali Kuserli, et al.
Psychiatry Research|August 9, 2014
Abnormal white matter integrity in long-term abstinent alcohol dependent patientsNabi Zorlu, Tugba Karavul Ucman, Fazil Gelal, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trialAybala Saricicek, Kathleen Maloney, Anjana Muralidharan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 17, 2009
Enhanced visual motion perception in major depressive disorderJulie D Golomb, Jenika R B McDavitt, Barbara M Ruf, et al.
Neuroimage. Clinical|February 10, 2019
Cortical thickness and surface area as an endophenotype in bipolar disorder type I patients and their first-degree relativesNefize Yalin, Aybala Saricicek, Ceren Hidiroglu, et al.
Psychiatry Research|May 19, 2012
Prefrontal cortical response to emotional faces in individuals with major depressive disorder in remissionRebecca Kerestes, Zubin Bhagwagar, Pradeep J Nathan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2014
Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943Aybala Saricicek, Jason Chen, Beata Planeta, et al.
The American Journal of Psychiatry|July 10, 2012
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorderAybala Saricicek, Irina Esterlis, Kathleen H Maloney, et al.
Molecular Psychiatry|May 21, 2026
White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysisMarjolein E A Barendse, Simon R Poortman, Christopher R K Ching, et al.
Pageof 2